Added to YB: 2024-10-07
Pitch date: 2024-10-04
LNTH [neutral]
Lantheus Holdings, Inc.
-37.88%
current return
Author Info
MMMT Wealth is a CPA who shares stock pitches in their newsletter. Sign up for the newsletter.
Company Info
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in diagnosis and treatment of heart, cancer, and other diseases worldwide.
Market Cap
$3.5B
Pitch Price
$107.24
Price Target
N/A
Dividend
N/A
EV/EBITDA
8.83
P/E
22.15
EV/Sales
2.46
Sector
Health Care Equipment and Supplies
Category
growth
3 Quality Stocks You Haven't Heard Of - Lantheus Holdings, Inc.
LNTH (waitlist): Radiopharmaceutical co. w/ 3 products (PYLARIFY, DEFINITY, TechneLite) growing 29%, 10%, 30.5%. M&A strategy expanding late-stage pipeline. Alzheimer's potential w/ MK-6240 & NAV-4694 acquisitions. Risks: high R&D/acquisition costs. 15.8x CY EPS, 5.0x EV/Sales. 2027 est: $768M rev, $270M net income (+330%). Waitlist for pullback.
Read full article (2 min)